The increased oxidative phosphorylation (OXPHOS) induced by SLC25A1 supports the resistance and adaptation of cancer cells to radiotherapy, platinum-derived agents, and other metabolic and respiration stress conditions [7]. Here, SLC25A1 is linked to cancer.